monoclonal antibodies
FDA Approves Enflonsia, Second RSV Antibody for Infants
The FDA has approved the second monoclonal antibody for the prevention of RSV in neonates and infants, ...
JUNE 10, 2025
CDC Urges Need for Boosters, COVID-19 Action Plan for Immunocompromised
With monoclonal antibodies lacking efficacy, the CDC urged all people, especially those who are immunocompromised, ...
FEBRUARY 13, 2023
Experimental Monoclonal Antibodies Show Promise Against Epstein-Barr Virus
Multiple sites of the Epstein-Barr virus appear to be vulnerable. A panel of investigational monoclonal antibodies ...
NOVEMBER 9, 2022
FDA Expands Authorization for Evusheld; Authorizes Bebtelovimab for COVID-19
The FDA revised the EUA for tixagevimab-cligavimab to allow a higher dose for PrEP and also granted a new EUA to ...
FEBRUARY 28, 2022
Arsenal Against Omicron Weakening
At least two Mabs available under the FDA emergency use authorization are not as effective against omicron as ...
JANUARY 12, 2022
Experimental mAb Reduces Hospitalization or Death Among Early and Late Users
Positive results presented at IDWeek 2021 about an experimental monoclonal antibody in reducing hospitalization and ...
OCTOBER 7, 2021
Pharmacists Authorized to Order and Administer COVID-19 Therapeutics Under PREP Act Declaration
An amendment to the PREP Act broadly addresses the pharmacist's role in providing COVID-19 therapeutics, including ...
SEPTEMBER 17, 2021
Tips for Using Regen-Cov
Carrie Adams, PharmD, the chief quality/transformation officer, at Meritus Health in Hagerstown, Md., offers things ...
SEPTEMBER 16, 2021
FDA Limits Use of COVID-19 Monoclonal Antibody Combination to States With Low Rates of Resistance
The FDA has revised its emergency use authorization for the monoclonal antibodies bamlanivimab and etesevimab to ...
SEPTEMBER 3, 2021
FDA Authorizes Use of Actemra for COVID-19
The FDA issued an EUA Actemra to treat hospitalized adults and children who are receiving systemic corticosteroids ...
JUNE 28, 2021
FDA Revokes EUA for Bamlanivimab Monotherapy for COVID-19; Still Authorized in Combination
Although the FDA revoked its EUA for bamlanivimab monotherapy, the agency said it could still be given ...
APRIL 21, 2021
Challenges to Uptake of Monoclonal Antibody Therapies for COVID-19: Lessons Learned
Issues identified in the introduction and uptake of monoclonal antibody therapies for COVID-19 offer key insights ...
APRIL 21, 2021